bisphosphonates

In 1995 when Merck & Co.'s Fosamax became the first approved drug in a group of medications called bisphosphonates, it was thought patients diagnosed with osteoporosis could be placed on the drugs indefinitely.

FDA Panel to Weigh Osteoporosis Drug Risks Jennifer Corbett Dooren 2011

Concern is rising that the group of popular drugs called bisphosphonates that slow bone loss carry a small risk of serious side effects, including a condition in which part of the jaw bone dies or thigh bones suffer a sudden, unusual fracture.

Yes, You Are Getting Shorter Melinda Beck 2011

(Youtube) "While it is not clear whether bisphosphonates are the cause, atypical femur fractures, a rare but serious type of thigh bone fracture, have been predominantly reported in patients taking bisphosphonates," particularly those taking the drugs for more than five years, the FDA said in a statement.

Bone drugs may cause fractures, FDA warns Rob Stein 2010

Fosamax, marketed by Merck & Co ., was the first approved drug in a group of medications called bisphosphonates.

Data Lacking for Osteoporosis Drugs Jennifer Corbett Dooren 2011

Older women who take a type of drug called bisphosphonates, which are meant to prevent fractures, face an increased risk of unusual fractures in their thigh bone, according to a large study in the Journal of the American Medical Association.

Study confirms osteoporosis drugs pose risk of thigh fractures in women 2011

The question of whether the drugs, called bisphosphonates, are associated with atypical femur fractures has been closely studied the past few years, in the wake of reports from orthopedic surgeons that they were seeing an increase in cases.

Rare Fractures Tied to Drug Amy Dockser Marcus 2011

The review involves a class of drugs known as bisphosphonates, which are commonly prescribed to treat osteoporosis and are designed to build bone mass.

FDA Will Review Fosamax, Boniva for Safety Jennifer Corbett Dooren 2010

The review involves a class of drugs known as bisphosphonates, which are commonly prescribed to treat osteoporosis and are designed to build bone mass.

FDA Will Review Fosamax, Boniva for Safety Jennifer Corbett Dooren 2010

The review involves a class of drugs known as bisphosphonates, which are commonly prescribed to treat osteoporosis and are designed to build bone mass.

FDA Will Review Fosamax, Boniva for Safety Jennifer Corbett Dooren 2010

Although drugs called bisphosphonates can slow down the body's resorption of older, brittle bone and reduce the risk of fractures in high-risk people by 30 to 40 percent, little is known about their use beyond 10 years.

Keys to a Healthy Life 2010